Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Walgreens PSE

This article was originally published in The Tan Sheet

Executive Summary

All pseudoephedrine-containing products will be sold behind the counter in Walgreens stores nationwide by the end of October, the company announces Aug. 5. The move builds on Walgreens' voluntary April decision to place single-ingredient pseudoephedrine products behind counters. The new policy aims to achieve consistency nationwide and was created out of "concern for the meth abuse facing many of our communities," the retailer says. Walgreens maintains that behind-the-counter sale is not connected to its settlement of a recent lawsuit in which it was cited for improper sale of the ingredient in Oklahoma stores...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel